Exploring the factors influencing the health-related quality of life in patients experiencing adverse drug reactions: a cross-sectional study

被引:1
作者
Pavan, Garapati [1 ]
Kumar, Manish [2 ,3 ]
Murti, Krishna [1 ,4 ]
Dhingra, Sameer [1 ,4 ]
Ravichandiran, V. [1 ]
机构
[1] Natl Inst Pharmaceut Educ & Res, Dept Pharm Practice, Hajipur, India
[2] Indira Gandhi Inst Med Sci, Dept Pharmacol, Patna, India
[3] Indira Gandhi Inst Med Sci, Adverse Drug React Monitoring Ctr, Patna, India
[4] Natl Inst Pharmaceut Educ & Res, Adverse Drug React Monitoring Ctr, Hajipur, India
关键词
ADRs; HRQoL; EQ-5D-5L; ADR severity; QoL; PREVALENCE; HOSPITALIZATIONS; SEVERITY; THERAPY; CANCER; COST;
D O I
10.1186/s41687-024-00790-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background This study aimed to assess the factors influencing health-related quality of life (HRQoL) in patients experiencing adverse drug reactions (ADRs) at a tertiary care public sector hospital. A cross-sectional study was conducted over a period of 18 months, and included both male and female patients aged 18 years and above. Patients who visited the outpatient and inpatient departments with complaints associated with ADRs were included in this study. HRQoL data were collected using the EuroQol-5 Dimension-5 Level (EQ-5D-5L) questionnaire to assess five dimensions of health on a five-level scale. Descriptive statistics, t-tests, and analysis of variance were used to analyze the data. Multivariate regression analysis was performed to identify the potential determinants of HRQoL. Results A total of 316 patients were included in the study among these participants, of which 54% were female, and 65% were from rural areas. The majority (68%) of the patients had moderately severe ADRs, and 63% of the participants had an income < 2.5 lakh Indian rupees (3009 USD). The mean EQ-5D-5L and EuroQoL Visual Analog Scale (EQ VAS) scores of the study participants were 0.714 and 69.73, respectively. The variables ADR severity, income, and age showed a significant difference (p < 0.05) in HRQoL. Conclusion This study provides insights into HRQoL among patients with ADRs and identifies the determinants of HRQoL. The findings of this study will contribute to improving patient-centered care and optimizing patient outcomes.
引用
收藏
页数:8
相关论文
共 45 条
[11]   Health-related quality of life among breast cancer patients in India [J].
Gupta, Nidhi ;
Pandey, Awadhesh Kumar ;
Dimri, Kislay ;
Jyani, Gaurav ;
Goyal, Aarti ;
Prinja, Shankar .
SUPPORTIVE CARE IN CANCER, 2022, 30 (12) :9983-9990
[12]   PREVENTABILITY AND SEVERITY ASSESSMENT IN REPORTING ADVERSE DRUG-REACTIONS [J].
HARTWIG, SC ;
SIEGEL, J ;
SCHNEIDER, PJ .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1992, 49 (09) :2229-2232
[13]   Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) [J].
Herdman, M. ;
Gudex, C. ;
Lloyd, A. ;
Janssen, M. F. ;
Kind, P. ;
Parkin, D. ;
Bonsel, G. ;
Badia, X. .
QUALITY OF LIFE RESEARCH, 2011, 20 (10) :1727-1736
[14]   Health-Related Quality of Life (HRQOL) Instruments and Mobility: A Systematic Review [J].
Hernandez-Segura, Natalia ;
Marcos-Delgado, Alba ;
Pinto-Carral, Arrate ;
Fernandez-Villa, Tania ;
Molina, Antonio J. .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (24)
[15]  
Jordan S, 2018, Adverse drug reactions, power, harm reduction, regulation and the ADRe profiles, DOI [10.3390/pharmacy6030102.Pharmacy, DOI 10.3390/PHARMACY6030102.PHARMACY]
[16]  
Jui-Chun CHAN, 2019, J Nurs Res, V27, P51
[17]   Health-related quality of life among Indian population: The EQ-5D population norms for India [J].
Jyani, Gaurav ;
Prinja, Shankar ;
Garg, Basant ;
Kaur, Manmeet ;
Grover, Sandeep ;
Sharma, Atul ;
Goyal, Aarti .
JOURNAL OF GLOBAL HEALTH, 2023, 13
[18]   Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set [J].
Jyani, Gaurav ;
Sharma, Atul ;
Prinja, Shankar ;
Kar, Sitanshu Sekhar ;
Trivedi, Mayur ;
Patro, Binod Kumar ;
Goyal, Aarti ;
Purba, Fredrick Dermawan ;
Finch, Aureliano Paolo ;
Rajsekar, Kavitha ;
Raman, Swati ;
Stolk, Elly ;
Kaur, Manmeet .
VALUE IN HEALTH, 2022, 25 (07) :1218-1226
[19]   Patient-reported adverse drug reactions and their influence on adherence and quality of life of chronic myeloid leukemia patients on per oral tyrosine kinase inhibitor treatment [J].
Kekale, Meri ;
Peltoniemi, Marikki ;
Airaksinen, Marja .
PATIENT PREFERENCE AND ADHERENCE, 2015, 9 :1733-1740
[20]  
Kind P., 2005, EQ-5D Concepts and Method. A, DOI DOI 10.1007/1-4020-3712-0